SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001161697-24-000023
Filing Date
2024-01-03
Accepted
2024-01-03 17:18:47
Documents
1
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 FOR 01-01-2024 form_3.html 3  
1 FORM 3 FOR 01-01-2024 form_3.xml 3 4663
  Complete submission text file 0001161697-24-000023.txt   6344
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 24 LUCILLE LANE DIX HILLS NY 11746
Business Address
Kalb Michael Wayne (Reporting) CIK: 0001678248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 24508174